Explore more
News
(Reuters) -GSK shares fell more than 6% on Friday to the bottom of Britain's blue-chip index after a U.S. FDA advisory panel ...
With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...
On a quest to bring its multiple myeloma antibody-drug conjugate Blenrep back to the U.S. | Members of the FDA's Oncologic ...
In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...
The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...
GSK plc (NYSE:GSK) is one of the best cheap stocks under $50 to buy now. On July 15, BofA analyst Sachin Jain maintained a ...
GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.
The Swedish defense company posted better-than-expected earnings and [raised its annual sales guidance]( ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback